S&P 500   3,370.97 (+0.31%)
DOW   28,053.23 (+0.94%)
QQQ   269.41 (-0.33%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
S&P 500   3,370.97 (+0.31%)
DOW   28,053.23 (+0.94%)
QQQ   269.41 (-0.33%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
S&P 500   3,370.97 (+0.31%)
DOW   28,053.23 (+0.94%)
QQQ   269.41 (-0.33%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
S&P 500   3,370.97 (+0.31%)
DOW   28,053.23 (+0.94%)
QQQ   269.41 (-0.33%)
AAPL   445.94 (-1.10%)
MSFT   206.55 (-0.82%)
FB   264.92 (+0.73%)
GOOGL   1,498.05 (+0.08%)
AMZN   3,146.88 (-0.04%)
NVDA   441.36 (-1.17%)
CGC   17.54 (-2.18%)
BABA   252.23 (+1.65%)
TSLA   1,405.29 (-0.94%)
GE   6.87 (+3.00%)
MU   48.71 (-0.90%)
AMD   79.64 (-3.16%)
T   30.49 (+0.96%)
F   7.29 (+2.82%)
ACB   10.07 (-1.47%)
GILD   68.67 (+0.23%)
NFLX   477.77 (-1.16%)
DIS   131.75 (+2.30%)
BAC   27.33 (+2.90%)
BA   185.59 (+3.44%)
Log in

NYSEARCA:EXIVVelocityShares 1X Daily Inverse VSTOXX Futures ETN Stock Price, Forecast & News

$7.45
0.00 (0.00 %)
(As of 04/8/2020)
Add
Today's Range
$7.40
Now: $7.45
$7.45
50-Day Range
$7.45
MA: $7.45
$7.45
52-Week Range
$5.00
Now: $7.45
$51.40
Volume429,792 shs
Average Volume418,409 shs
Market Capitalization$2.98 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A


Basic Details

Issuer UBS
Fund NameVelocityShares 1X Daily Inverse VSTOXX Futures ETN
Tax Classification
SymbolNYSEARCA:EXIV
Inception Date5/2/2017
Fund Manager
WebN/A
PhoneN/A

Fund Focus

Asset ClassMulti Asset
BenchmarkVSTOXX Short-Term Futures Inverse Investable Index
CategoryAbsolute Returns
FocusVolatility
Development LevelDeveloped Markets
RegionEurope

Fund Statistics

Assets Under Management$27.06 million
Average Daily Volume$3,597.00
Discount/Premium1.63%

ETF Expenses

Management Fee0.00%
Other Expenses0.00%
Total Expenses0.00%
Fee Waiver0.00%
Net Expenses0.00%

Administrator, Advisor and Custodian

Administrator
Advisor
Custodian
Distributor
Transfer Agent
Trustee
Lead Market MakerVirtu Financial
$7.45
0.00 (0.00 %)
(As of 04/8/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive EXIV News and Ratings via Email

Sign-up to receive the latest news and ratings for EXIV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











VelocityShares 1X Daily Inverse VSTOXX Futures ETN (NYSEARCA:EXIV) Frequently Asked Questions

How has VelocityShares 1X Daily Inverse VSTOXX Futures ETN's stock been impacted by Coronavirus?

VelocityShares 1X Daily Inverse VSTOXX Futures ETN's stock was trading at $13.03 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EXIV shares have decreased by 42.8% and is now trading at $7.45.
View which stocks have been most impacted by COVID-19
.

Has VelocityShares 1X Daily Inverse VSTOXX Futures ETN been receiving favorable news coverage?

Media headlines about EXIV stock have been trending neutral this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. VelocityShares 1X Daily Inverse VSTOXX Futures ETN earned a daily sentiment score of 0.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
View the latest news about VelocityShares 1X Daily Inverse VSTOXX Futures ETN
.

What other stocks do shareholders of VelocityShares 1X Daily Inverse VSTOXX Futures ETN own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VelocityShares 1X Daily Inverse VSTOXX Futures ETN investors own include SciClone Pharmaceuticals (SCLN), GDS (GDS), Flaherty&Crumrine Prfrd Scts Incm Fd (FFC) and E*TRADE Financial (ETFC).

What is VelocityShares 1X Daily Inverse VSTOXX Futures ETN's stock symbol?

VelocityShares 1X Daily Inverse VSTOXX Futures ETN trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "EXIV."

How do I buy shares of VelocityShares 1X Daily Inverse VSTOXX Futures ETN?

Shares of EXIV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is VelocityShares 1X Daily Inverse VSTOXX Futures ETN's stock price today?

One share of EXIV stock can currently be purchased for approximately $7.45.

How big of a company is VelocityShares 1X Daily Inverse VSTOXX Futures ETN?

VelocityShares 1X Daily Inverse VSTOXX Futures ETN has a market capitalization of $2.98 million.

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.